Needham Maintains Buy on Boston Scientific, Lowers Price Target to $57

Benzinga Newsdesk www.benzinga.com Negative 67.0%

Neg 67% Neu 0% Pos 0%

Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $77 to $57.